The Filing Desk

Actinium Pharmaceuticals vs Clene

Actinium Pharmaceuticals ATNM · Clene CLNN · Pharmaceuticals

Clene reported revenue of $0 million in fiscal 2025, 2.0 times Actinium Pharmaceuticals' $0 million in fiscal 2025. Actinium Pharmaceuticals had an operating margin of -40274.4%, against -11541.5% at Clene. Free cash flow was −$25 million at Actinium Pharmaceuticals and −$19 million at Clene.

Side by side

Actinium PharmaceuticalsClene
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$0M$0M
Revenue growth—−41.5%
Revenue growth a year, last 5 years—0.0%
Gross margin—78.5%
Operating margin−40,274.4%−11,541.5%
Net margin−37,652.2%−13,086.5%
Free cash flow−$25M−$19M
Free cash flow margin−27,426.7%−9,292.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count3.7%41.8%
Last close$1.07$3.50
P/E at the last close3.2×—
Insider trades, last 12 months—bought $250,904, sold $5.8 million
Piotroski F-score—2 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Actinium PharmaceuticalsClene
Operating margin
Percent of revenue
Actinium PharmaceuticalsClene
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Actinium PharmaceuticalsClene

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Actinium Pharmaceuticals and Clene pages.